From April 1, 2022 to June 30, 2022, the company has repurchased 658,000 shares, representing 1.31% for $23.26 million. With this, the company has completed the repurchase of 4,416,666 shares, representing 8.39% for $187.87 million under the buyback announced on November 11, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | -1.54% | -11.11% | -20.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.00% | 102M | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Tranche Update on Emergent BioSolutions Inc.'s Equity Buyback Plan announced on November 11, 2021.